Therapeutic Asset Ratings
1,553 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ABO2109
Non-Small Cell Lung Cancer NSCLC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Early P1
C
(39)
Acnk-Sup003 Cell
B-Cell Non-Hodgkin Lymphoma
Donghua Zhang
Early P1
C
(39)
ADVANCED-PLATELET RICH FIBRIN
Pain Syndrome
Aalborg University Hospital
Early P1
C
(39)
AIR
Idiopathic Pulmonary Fibrosis
Dr. Denis O'Donnell
Early P1
C
(39)
Albuterol
Asthma
Tongji University
Early P1
C
(39)
ALECTINIB
Breast Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Ovarian Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
ALECTINIB
Ovarian Cancer
OHSU Knight Cancer Institute
Early P1
C
(39)
Allogeneic Umbilical Cord Blood
Nervous System Disorder
The Medical Pavilion Bahamas
Early P1
C
(39)
Allogeneic Umbilical Cord Blood
Spinal Cord Injury
The Medical Pavilion Bahamas
Early P1
C
(39)
ALOES
Bladder Pain Syndrome
Wake Forest University Health Sciences
Early P1
C
(39)
Aloe vera polysaccharide extract
Interstitial Cystitis
Wake Forest University Health Sciences
Early P1
C
(39)
Alpelisib
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Prostate Carcinoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Alpelisib
Soft Tissue Sarcoma
OHSU Knight Cancer Institute
Early P1
C
(39)
Angong Niuhuang Pill
Cognitive Disorder
Second Affiliated Hospital, School of Medicine, Zhejiang University
Early P1
C
(39)
Ankaferd Blood Stopper
Cirrhosis Of Liver
British University In Egypt
Early P1
C
(39)
Anti Alpp Car-T Cells Treatment
Recurrent or Metastatic Solid Tumors With Positive ALPP
Haifeng Qin
Early P1
C
(39)
Anti-Cd19 Car T-Cells
Leukemia
Affiliated Hospital of Nantong University
Early P1
C
(39)
Anti-Cd19 Car T-Cells
Lymphoma
Affiliated Hospital of Nantong University
Early P1
C
(39)
Anti-Cd19-Car Γδt
Idiopathic Inflammatory Myopathies
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Early P1
C
(39)
Showing 201 to 225 of 1,553 assets
Previous
Page 9 of 63
Next
